Search

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Friday, December 17, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Craig B. Thompson Named to AMNY Metro and PoliticsNY’s Power Players in Health Care List Craig B. Thompson Craig B. Thompson, MD , President and CEO, has been named to the first AMNY

Our students’ research is recognized with the Geoffrey Beene Graduate Student Fellowships, the Catell Fellowship, the Olayan Fellowship, and the Palestin Fellowship.

… Saturday, October 1, 2011 Geoffrey Beene Graduate Student Fellowships Announced Three second-year students — Robert Bowman, Jenny Karo, and Gregory Mazo — received Geoffrey Beene Graduate Student Fellowships . Recipients are selected at the end of their first year of study based on academic excellence

Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) surveillance. However, if patients with a high risk of brain metastasis after surgical resection can be identified, surveillance and prophylactic treatment with CNS-directed therapies may improve outcomes.

… Monday, March 24, 2025 Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) surveillance. However, if patients with a high risk of brain metastasis after

The U.S. Food and Drug Administration (FDA) recently granted accelerated approval to selpercatinib (Retevmo™) for lung and thyroid cancers with RET (REarranged during Transfection) gene mutations or fusions.

… Tuesday, May 26, 2020 Update: On September 21, 2022, the U.S. Food and Drug Administration (FDA) expanded the approval of selpercatinib (Retevmo TM ) beyond treating lung and thyroid cancers. The drug is now approved for adults with any locally advanced or metastatic solid tumor carrying a RET gene fusion

Decreasing values for apparent diffusion coefficient (ADC) mapping derived from MRI may indicate the development of trilateral retinoblastoma in pediatric patients with bilateral retinoblastoma.

… Monday, August 5, 2019 Decreasing values for apparent diffusion coefficient (ADC) mapping derived from MRI may indicate the development of trilateral retinoblastoma in pediatric patients with bilateral retinoblastoma, according to our retrospective study published recently in the Journal of Pediatric

Our research shows that most women diagnosed with either breast or gynecologic cancer have concerns about how treatment may affect their sexual and vaginal health. Moreover, they want their healthcare providers to initiate the discussion.

… Friday, November 10, 2017 Our research shows that most women diagnosed with either breast or gynecologic cancer have concerns about how treatment may affect their sexual and vaginal health. Moreover, they want their healthcare providers to initiate the discussion. At Memorial Sloan Kettering Cancer Center

Omar Abdel-Wahab, MD, Chair of the Molecular Pharmacology Program at Sloan Kettering Institute (SKI); Evnin Family Chair in Molecular Pharmacology and Attending Physician on the Leukemia Service at Memorial Sloan Kettering Cancer Center (MSK), has been elected to the National Academy of Medicine (NAM), one of the most prestigious honors in the fields of health and medicine.

… Monday, October 20, 2025 Omar Abdel-Wahab, MD, Chair of the Molecular Pharmacology Program at Sloan Kettering Institute (SKI); Evnin Family Chair in Molecular Pharmacology and Attending Physician on the Leukemia Service at Memorial Sloan Kettering Cancer Center (MSK), has been elected to the National

In mice, drugs that change the way proteins are assembled appear to make checkpoint inhibitor drugs work better.

… Thursday, June 24, 2021 Like an invading army, cancer cells can have different modes of action. Some announce their arrival loudly while others wreak havoc by sneaking under the radar. Immunotherapy drugs called checkpoint inhibitors work best against the less stealthy type. Their role is to take the

A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Memorial Sloan Kettering Cancer Center (MSK), Dana-Farber Cancer Institute, and Roswell Park Comprehensive Cancer Center report in a new study.

… Wednesday, September 28, 2022 A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Memorial Sloan Kettering Cancer Center (MSK), Dana-Farber

Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division.

… Friday, October 18, 2013 Summary Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division. Emily Foley, a laboratory investigator in the Sloan Kettering Institute Cell Biology Program , studies the molecular mechanisms